+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Direct-to-Consumer Laboratory Testing Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035)

  • PDF Icon

    Report

  • 350 Pages
  • May 2026
  • Region: Global
  • Expert Market Research
  • ID: 6163320
The direct-to-consumer laboratory testing market was valued at USD 15.72 Billion in 2025. It is poised to grow at a CAGR of 26.80% during the forecast period of 2026-2035, and reach USD 168.91 Billion by 2035. The market growth is driven by the increasing consumer preference for DTC lab test services, home collection kits, and online blood tests, driving market growth, enabling convenient self-ordered diagnostics and personalized health insights

Key Market Trends and Insights

  • By test type, genetic testing expected to lead the market, capturing more than 38% of the market share in the historical period.
  • Based on sample type, saliva retained over 46% of market in the historical period.
  • By distribution channel, online platforms/websites contributed approximately 70% of revenue share in the historical period.

Market Size and Forecast

  • Market Size (2025): USD 15.72 Billion
  • Projected Market Size (2035): USD 168.91 Billion
  • CAGR (2026-2035): 26.80%

Direct-To-Consumer Laboratory Testing Market Overview

The market is expanding rapidly, driven by growing demand for DTC lab test services, home collection kits, and self-ordered diagnostics. Consumers increasingly prefer convenient online access to wellness testing, STI testing, and biomarker panels. Rising awareness of health monitoring, coupled with digital platforms offering subscription lab testing and CBC test online, is accelerating market adoption and growth globally. The market reached a value of approximately USD 15.72 Billion in 2025.

Direct-To-Consumer Laboratory Testing Market Growth Drivers

Increasing Access to At Home Diagnostic Testing Solutions to Propel the Market Demand

Growing consumer demand for convenient STI testing and privacy focused diagnostics, along with rising telehealth uptake and home sample collection services, is driving market growth. For instance, in January 2026, OraSure Technologies submitted FDA applications for a rapid molecular self test for STIs and an at home urine collection device, expanding consumer access and expected to accelerate adoption of direct to consumer testing solutions in the forecast period.

Direct-To-Consumer Laboratory Testing Market Trends

Key trends shaping the market include rising adoption of DTC lab test, self ordered diagnostics, home collection kits, online blood tests, biomarker panels, and subscription lab testing.

Rising Integration of Telehealth Platforms to Boost the Market Expansion

The increasing integration of telehealth platforms with direct-to-consumer (DTC) laboratory testing is emerging as a significant trend shaping the market landscape. For instance, in November 2025, Hims & Hers partnered with Quest Diagnostics to introduce DTC lab testing services, enabling consumers to independently access diagnostic tests and identify potential health risks. This trend is expected to enhance accessibility, streamline care delivery, and accelerate the adoption of consumer-centric diagnostic solutions across the market.

Direct-To-Consumer Laboratory Testing Market Segmentation

Market Breakup by Sample Type

  • Blood
  • Urine
  • Saliva
  • Others

Market Breakup by Test Type

  • Genetic Testing
  • Disease Risk Assessment Testing
  • CBC
  • Diabetes Testing
  • TSH Testing
  • Others

Market Breakup by Distribution Channel

  • Online Platforms/Websites
  • Mobile Applications
  • Physical Retail Locations
  • Telemedicine Services
  • Others

Market Breakup by End User

  • Hospitals
  • Clinics
  • Specialty Labs
  • Diagnostic Centres
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Direct-To-Consumer Laboratory Testing Market Share

Saliva Expected to Dominate the Market Share by Sample Type

Saliva samples accounted for over 46% of the market share in the historical period. The widespread availability of home collection kit services enabled consumers to collect samples conveniently at home and access results online. This trend demonstrates increasing adoption of self-directed testing solutions, enhancing accessibility, convenience, and consumer engagement, supporting market growth during the forecast period.

Direct-To-Consumer Laboratory Testing Market Analysis by Region

North America held approximately 39% share in the historical period, driven by advanced healthcare infrastructure, digital platforms, and widespread consumer awareness. The region’s extensive adoption of online blood test services allows individuals to access personalized testing and health insights remotely. This adoption trend reinforces North America’s leadership and is expected to sustain market dominance throughout the forecast period.

Leading Players in the Direct-To-Consumer Laboratory Testing Market

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

LabCorp

LabCorp Holdings Inc., headquartered in Burlington, North Carolina, was established in 1978. It provides extensive diagnostic services and DTC lab test options through consumer initiated testing services, enabling customers to order tests online and receive results via secure portals, expanding access to personalized diagnostics. LabCorp’s strong brand and broad test portfolio support consumer autonomy in health management.

Quest Diagnostics

Quest Diagnostics, headquartered in Secaucus, New Jersey, was established in 1967 and is a major clinical laboratory services provider in the US and abroad. Quest offers a range of diagnostics including online blood tests and consumer accessible services such as self ordered diagnostics via QuestDirect, letting individuals order and manage CBC test online and other lab tests without physician referrals.

Everlywell

Everlywell is a direct to consumer health testing company founded in 2014 and based in Austin, Texas. It offers home collection kit services that let users collect samples at home and access lab results online for wellness, hormone, and sexual health tests. In March 2026, Everlywell expanded access to a gut microbiome test through a partnership with Jona, enhancing its portfolio of consumer focused diagnostics.

LetsGetChecked

LetsGetChecked, co headquartered in Dublin, Ireland, and New York, USA, was founded in 2015 and delivers at home health testing and telehealth services. It enables individuals to order confidential health assessments, including wellness testing and infectious disease panels, from anywhere. In January 2025, the company secured USD 165 million funding to expand its end to end testing and care offerings globally, strengthening its consumer focused diagnostics presence.

Other key players in the market are HealthTap, AncestryDNA, Veritas Genetics, MyHeritage, Color Genomics, Helix, Orig3n, Pathway Genomics, Thermo Fisher Scientific, Genome Medical, and HealthCheck.

Key Questions Answered in the Direct-To-Consumer Laboratory Testing Market Report

  • What was the direct-to-consumer laboratory testing market value in 2025?
  • What is the direct-to-consumer laboratory testing market forecast outlook for 2026-2035?
  • What major factors aid the demand for direct-to-consumer laboratory testing market?
  • How has the market performed so far, and how is it anticipated to perform in the coming years?
  • What are the market’s major drivers, opportunities, and restraints?
  • What are the major direct-to-consumer laboratory testing market trends?
  • Which sample type is expected to dominate the market segment?
  • Which test type is expected to dominate the market segment?
  • Which distribution channel is expected to dominate the market segment?
  • Which end user is expected to dominate the market segment?
  • Who are the key players in the direct-to-consumer laboratory testing market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Direct-to-Consumer Laboratory Testing Market Overview
3.1 Global Direct-to-Consumer Laboratory Testing Market Historical Value (2019-2025)
3.2 Global Direct-to-Consumer Laboratory Testing Market Forecast Value (2026-2035)
4 Global Direct-to-Consumer Laboratory Testing Market Landscape
4.1 Global Direct-to-Consumer Laboratory Testing Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Direct-to-Consumer Laboratory Testing Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
5 Global Direct-to-Consumer Laboratory Testing Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Direct-to-Consumer Laboratory Testing Market Segmentation
6.1 Global Direct-to-Consumer Laboratory Testing Market by Sample Type
6.1.1 Market Overview
6.1.2 Blood
6.1.3 Urine
6.1.4 Saliva
6.1.5 Others
6.2 Global Direct-to-Consumer Laboratory Testing Market by Test Type
6.2.1 Market Overview
6.2.2 Genetic Testing
6.2.3 Disease Risk Assessment Testing
6.2.4 CBC
6.2.5 Diabetes Testing
6.2.6 TSH Testing
6.2.7 Others
6.3 Global Direct-to-Consumer Laboratory Testing Market by Distribution Channel
6.3.1 Market Overview
6.3.2 Online Platforms/Websites
6.3.3 Mobile Applications
6.3.4 Physical Retail Locations
6.3.5 Telemedicine Services
6.3.6 Others
6.4 Global Direct-to-Consumer Laboratory Testing Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Clinics
6.4.4 Speciality Labs
6.4.5 Diagnostic Centres
6.4.6 Others
6.5 Global Direct-to-Consumer Laboratory Testing Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Direct-to-Consumer Laboratory Testing Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Direct-to-Consumer Laboratory Testing Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Direct-to-Consumer Laboratory Testing Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Direct-to-Consumer Laboratory Testing Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Direct-to-Consumer Laboratory Testing Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 LabCorp
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Quest Diagnostics
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Everlywell
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 LetsGetChecked
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 HealthTap
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 AncestryDNA
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Veritas Genetics
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 MyHeritage
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 Color Genomics
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Helix
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
17.11 Orig3n
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.11.5 Certifications
17.12 Pathway Genomics
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisition
17.12.5 Certifications
17.13 Thermo Fisher Scientific
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisition
17.13.5 Certifications
17.14 Genome Medical
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisition
17.14.5 Certifications
17.15 HealthCheck
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisition
17.15.5 Certifications
18 Global Direct-to-Consumer Laboratory Testing Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • LabCorp
  • Quest Diagnostics
  • Everlywell
  • LetsGetChecked